The EuroPainClinics® epiduroscopy study was presented at the SOPATE 2017 Symposium in London
30. 10. 2017
Another important appreciation for EuroPainClinics® clinical research!
The Clinical Study EuroPainClinics® Study II, which examines the benefits of epiduroscopy, was accepted for presentation by the academic community of the prestigious international symposium on clinical trials in pain therapy “SOPATE 2017 The Symposium on Clinical Pain Trials in Europe”. The study was presented in the form of a presentation poster “The Effect of Drugs Administration in the Epidural Space During Epiduroscopy”. The event, which took place from 25 to 26 October in London, was attended by representatives of EuroPainClinics® Management MUDr. Róbert Rapčan, MBA, FIPP, Medical Director EuroPainClinics®, and MUDr. Miroslav Burianek, MBA, Chairman of EPC Health Invest SE, and MUDr. Ladislav Kočan, PhD., Clinical Research Manager EuroPainClinics®.
The SOPATE LONDON 2017 Symposium was organized by the European Pain Federation (EFIC), a multidisciplinary organization of research and medicine for pain management, which brings together 37 national sections approved by the International Association for the Study of Pain (IASP) . The Symposium offered the researchers, doctors and other professionals who were present not only the latest findings and approaches to pain management, based on the results of clinical research and studies, but also real possibilities for improving and further developing studies.